COVID19

Health Tech in 2022

In this Q&A, hear from Abbott's chief economist on the future of health technology and its economic impact.
Blog

The traditional healthcare model has become more agile and connected seemingly overnight, just as technology — like Abbott’s COVID-19 rapid tests and FreeStyle Libre system — is empowering people to take ownership of their health like never before.

Continuing Support for Those Affected by COVID-19

Article

Our employees are passionate about many causes and embrace opportunities to make a difference. To support employee volunteerism during the COVID-19 pandemic, we created an online portal for them to find virtual volunteer opportunities more easily. We also hosted virtual volunteer activities for employees and their families, such as making inspirational cards for older adults who would benefit from friendly connections during this deeply isolating time.

The Dynamic Future of Life-Saving Medicine

Changing the way therapies work, and the changing work of making therapies.
Article

By Noel Maestre, PE, LEED AP, Vice President, Life Sciences

This article originally appeared in our 2021 Horizons Life Sciences report, which includes insights from industry leaders and CRB’s experts. Get your copy of the report here.

Engineering Impact: Our Ongoing COVID-19 Response

Excerpts from the 2021 Medtronic Integrated Performance Report
Article

COVID-19 spurred collaboration and inspired us to reach new levels of innovation. We moved quickly and decisively, in partnership with the Medtronic Foundation, to lessen the impact of the pandemic on our employees, patients, and healthcare professionals, and global communities. An overview of our key actions follows, with more details about our pandemic response included throughout this report.

Employees and their families

Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets

$5 billion bond is the largest of its kind from any sector and the first issued by a generic medicines company
Summary: 
  • $5 billion bond is the largest of its kind from any sector and the first issued by a generic medicines company
  • The bond is tied to targets that include improving access to medicines in low- and middle-income countries (LMICs) and reducing greenhouse gas (GHG) emissions
Press Release
  • $5 billion bond is the largest of its kind from any sector and the first issued by a generic medicines company
  • The bond is tied to targets that include improving access to medicines in low- and middle-income countries (LMICs) and reducing greenhouse gas (GHG) emissions

Pucks for PPE: Project Northern Lights and RESOLVE Canada Announce New NHL and CDC Foundation-Supported Initiative to Provide PPE to 7 NHL Cities

“Pucks for PPE” is a new initiative to provide PPE to marginalized populations in seven Canadian cities.
Press Release

June 3, 2021 /3BL Media/ - Project Northern Lights (PNL) and RESOLVE Canada are excited to announce our most recent collaboration: Pucks for PPE. Funded by the CDC Foundation and the National Hockey League (NHL), Pucks for PPE is a project that aims to deliver protective equipment and other supplies to a range of marginalized populations in each Canadian city with an NHL team.

VisionSpring Raises $1.5 Million for India COVID-19 Response and Will Deliver More Than 1,000 Oxygen Concentrators to Expand Care

Social Enterprise Deploys Global Team to Procure Personal Protective Equipment and Oxygen Concentrators in Race to Meet Medical Needs in India
Press Release

NEW DELHI, INDIA, May 20, 2021 /3BL Media/ - VisionSpring (www.visionspring.org), the pioneering social enterprise, has secured an initial $1.5 million in emergency response commitments for the COVID-19 crisis in India and will deliver more than 1,000 oxygen concentrators and other COVID-19 care and safety supplies to frontline health workers.

Pages

Subscribe to COVID19